NO20032248L - Ny anvendelse av kombinerte 5-HT1A-agonister og selektive inhibitorer for serotoningjenopptaksinhibitorer - Google Patents

Ny anvendelse av kombinerte 5-HT1A-agonister og selektive inhibitorer for serotoningjenopptaksinhibitorer

Info

Publication number
NO20032248L
NO20032248L NO20032248A NO20032248A NO20032248L NO 20032248 L NO20032248 L NO 20032248L NO 20032248 A NO20032248 A NO 20032248A NO 20032248 A NO20032248 A NO 20032248A NO 20032248 L NO20032248 L NO 20032248L
Authority
NO
Norway
Prior art keywords
inhibitors
combined
serotonin reuptake
new use
ht1a agonists
Prior art date
Application number
NO20032248A
Other languages
English (en)
Other versions
NO20032248D0 (no
Inventor
Gerd Bartoszyk
Ewen Sedman
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20032248L publication Critical patent/NO20032248L/no
Publication of NO20032248D0 publication Critical patent/NO20032248D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20032248A 2000-11-20 2003-05-19 Ny anvendelse av kombinerte 5-HT1A-agonister og selektive inhibitorer for serotoningjenopptaksinhibitorer NO20032248D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00125409 2000-11-20
PCT/EP2001/012686 WO2002039989A1 (en) 2000-11-20 2001-11-02 Novel use of combined 5-ht1a agonists and selective serotonin reuptake inhibitors

Publications (2)

Publication Number Publication Date
NO20032248L true NO20032248L (no) 2003-05-19
NO20032248D0 NO20032248D0 (no) 2003-05-19

Family

ID=8170432

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032248A NO20032248D0 (no) 2000-11-20 2003-05-19 Ny anvendelse av kombinerte 5-HT1A-agonister og selektive inhibitorer for serotoningjenopptaksinhibitorer

Country Status (19)

Country Link
US (1) US7479492B2 (no)
EP (1) EP1335716A1 (no)
JP (1) JP2004513916A (no)
KR (1) KR20030048477A (no)
CN (1) CN1541093A (no)
AR (1) AR031463A1 (no)
AU (2) AU2180302A (no)
BR (1) BR0115434A (no)
CA (1) CA2429216C (no)
CZ (1) CZ20031448A3 (no)
HU (1) HUP0400504A3 (no)
MX (1) MXPA03004341A (no)
NO (1) NO20032248D0 (no)
PL (1) PL361617A1 (no)
RU (1) RU2302243C2 (no)
SK (1) SK6442003A3 (no)
UA (1) UA76130C2 (no)
WO (1) WO2002039989A1 (no)
ZA (1) ZA200304757B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10326939A1 (de) * 2003-06-16 2005-01-05 Merck Patent Gmbh Indol-Derivate
EP1732610A2 (en) 2004-03-26 2006-12-20 Baylor University Targeted serotonin reuptake inhibitors
WO2006006152A2 (en) * 2004-07-08 2006-01-19 Ramot At Tel-Aviv University Ltd Treatment of disorders and diseases of the colon
US7994331B2 (en) 2005-07-13 2011-08-09 Msd K.K. Heterocycle-substituted benzimidazole derivative
EP2044043B2 (en) 2006-06-16 2021-03-03 H. Lundbeck A/S 1- ý[- (2, 4-dimethylphenylsulfanyl) -phenyl]piperazine hydrobromide as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
TW200848411A (en) * 2007-03-20 2008-12-16 Lundbeck & Co As H Novel therapeutic uses of 1-[2-(2, 4-dimethylphenylsulfanyl)phenyl]-piperazine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2222768B (en) * 1988-06-17 1992-01-22 Nat Res Dev Analgesic compounds and compositions
US5589511A (en) * 1990-08-13 1996-12-31 Sepracor Inc. Method for treating migraine headaches using optically pure S(+) fluoxetine
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5434174A (en) * 1992-07-17 1995-07-18 Eli Lilly And Company Isoxazole derivatives for the treatment of irritable bowel syndrome
DE4333254A1 (de) * 1993-09-30 1995-04-06 Merck Patent Gmbh Piperidine und Piperazine
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems
DE19512639A1 (de) * 1995-04-05 1996-10-10 Merck Patent Gmbh Benzonitrile und -fluoride
US5912256A (en) * 1996-06-20 1999-06-15 Eli Lilly And Company Compounds having effects on serotonin-related systems
UA56185C2 (uk) * 1996-09-30 2003-05-15 Пфайзер Інк. Аралкіл- та аралкіліденгетероциклічні лактами та іміди, фармацевтична композиція та спосіб лікування
GB9911863D0 (en) * 1999-05-21 1999-07-21 Knoll Ag Therapeutic agents
TW518218B (en) 1999-05-27 2003-01-21 Merck Patent Gmbh Pharmaceutical compositions comprising 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine or its physiologically acceptable salts for use in the treatment of sub-type anxiety disorders

Also Published As

Publication number Publication date
CA2429216C (en) 2012-08-07
JP2004513916A (ja) 2004-05-13
AU2180302A (en) 2002-05-27
PL361617A1 (en) 2004-10-04
ZA200304757B (en) 2004-09-20
HUP0400504A3 (en) 2006-02-28
RU2302243C2 (ru) 2007-07-10
CN1541093A (zh) 2004-10-27
KR20030048477A (ko) 2003-06-19
AU2002221803B2 (en) 2007-02-15
NO20032248D0 (no) 2003-05-19
AR031463A1 (es) 2003-09-24
HUP0400504A2 (hu) 2004-06-28
UA76130C2 (en) 2006-07-17
MXPA03004341A (es) 2003-08-19
BR0115434A (pt) 2003-10-07
CA2429216A1 (en) 2002-05-23
CZ20031448A3 (cs) 2003-09-17
SK6442003A3 (en) 2003-09-11
US20040014771A1 (en) 2004-01-22
WO2002039989A1 (en) 2002-05-23
EP1335716A1 (en) 2003-08-20
US7479492B2 (en) 2009-01-20

Similar Documents

Publication Publication Date Title
IS2529B (is) Nýjar spírótrísýklískar afleiður og notkun þeirra sem fosfódíesterasa-7-hindrar
NO20032465D0 (no) Nye mandelsyre-derivater og anvendelse derav som trombininhibitorer
EE200300478A (et) Tsüklopropüülindooli derivaadid kui selektiivsed serotoniini tagasihaarde inhibiitorid
IS8806A (is) Fenýl-píperidín afleiður sem serótónín endurupptökuhindrar
NO20005265D0 (no) Substituerte benzamider, deres fremstilling og anvendelse som inhibitorer av cystin-proteaser
IL148497A0 (en) Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
IS7040A (is) 5-HT viðtakabindlar og notkun þeirra
NO20031482D0 (no) Nye tiadiazoler og oksadiazoler, og anvendelse derav som fosfodiesterase-7inhibitorer
NO20030304L (no) Ny kombinasjon av serotoninagonist (5HT2) og antagonist (5HT6) som farmasoytisk formulering
NO20005400D0 (no) Kinoloner anvendt som MRS-inhibitorer og baktericider
DE60106968D1 (de) Kombination von gaba agonisten und sorbitol dehydrogenase inhibitoren
NO20043907L (no) Partielle og fullstendige agonister av A1-adenosinreseptorer
NO20033854D0 (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
ATE499096T1 (de) Kombination von serotonin-wiederaufnahme-hemmern und agomelatin
NO20032248D0 (no) Ny anvendelse av kombinerte 5-HT1A-agonister og selektive inhibitorer for serotoningjenopptaksinhibitorer
EE200300498A (et) Fenüül-heterotsüklüüleetri derivaadid kui serotoniini tagasihaarde inhibiitorid
NO20032148D0 (no) Nye anvendelser av kombinerte 5-HT1A-agonister og serotoningjenopptaksinhibitorer
NO20025509D0 (no) Ny polymorf av torasemid
PT1146041E (pt) Derivados de heterocicloalquilbenzociclobutano e de heteroarilbenzociclobutano e sua utilizacao como inibidores de recaptura da serotonina e da noradrenalina
NO20033163L (no) Ny anvendelse av iloperidon
DK1259523T3 (da) Pluraflaviner og derivater deraf, fremgangsmåde til fremstilling og anvendelse deraf
NO20030812D0 (no) Bifenylderivater og anvendelse derav som integrininhibitorer
NO20035647L (no) Ny anvendelse av cyclolignaner og nye cycloliganer
DK1347963T3 (da) Benzofuran- og benzothiophenderivater som selektive COX-2-inhibitorer
NO20025885L (no) Derivater av 4,5-dihydro-tiazo-2-ylamin og deres anvendelse som NO-syntaseinhibitorer